Attovia Therapeutics (ATTO) awards 538,300 options at $17.00 strike price
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. reported a grant of stock options covering 538,300 shares of common stock with an exercise price of $17.00 per share. The options expire on August 3, 2036. According to the vesting schedule, 25% vests on August 4, 2027, with the remainder vesting in equal monthly installments over the following 36 months, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Attovia Therapeutics, Inc.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 538,300 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 538,300 shares (Direct)
Footnotes (1)
- F1. 25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.
Key Figures
Options granted: 538,300 shares
Exercise price: $17.00 per share
Underlying shares: 538,300 shares
+3 more
6 metrics
Options granted
538,300 shares
Stock Option (Right to Buy) award reported in the Form 4
Exercise price
$17.00 per share
Conversion or exercise price of the stock options
Underlying shares
538,300 shares
Common stock underlying the reported stock option grant
Expiration date
August 3, 2036
Expiration of the granted stock options
Initial vesting date
August 4, 2027
25% of options vest on this date, per footnote
Vesting period for remainder
36 months
Remaining 75% vests in equal monthly installments thereafter
Key Terms
Stock Option (Right to Buy), exercise price, vesting, underlying security
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 17.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the options shall vest on August 4, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: Common Stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Attovia Therapeutics (ATTO) report in this Form 4?
Attovia Therapeutics reported a grant of stock options for 538,300 shares of common stock at an exercise price of $17.00 per share, expiring on August 3, 2036, as reflected in the Form 4 filing.
What is the exercise price of the new stock options reported by ATTO?
The newly granted stock options have an exercise price of $17.00 per share. These options relate to 538,300 shares of Attovia Therapeutics common stock and are scheduled to expire on August 3, 2036, subject to the stated vesting conditions.
What is the vesting schedule for the Attovia Therapeutics (ATTO) stock options granted?
According to the filing, 25% of the options vest on August 4, 2027, while the remaining 75% vest in equal monthly installments over the following 36 months, contingent on continued service to Attovia Therapeutics.
Are the Attovia Therapeutics (ATTO) options immediately exercisable?
The options are not fully vested immediately. Only after August 4, 2027 does 25% vest, with the remaining 75% vesting in monthly installments over the next 36 months, all subject to continued service to the issuer.